The contribution of hybrid imaging to radionuclide therapy
Radionuclide therapy is a rapidly evolving field considered a safe and effective targeted approach to treating many types of cancer. Radiation is systemically or locally delivered using pharmaceuticals that either bind preferentially to cancer cells or accumulate at the site of treatment by physiological mechanisms. Almost all radionuclides used in radionuclide therapy emit photons that […]
Carla Aberu, Paul Gape, Jan Taprogge, Glen Fluxx
The Royal Marsden Hospital, The Institute of Cancer Research